For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
0
views
115
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      1,797
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      Contemporary pharmacological treatment and management of heart failure

      Author(s):
      Publication date (Electronic):
      Journal: Nature Reviews Cardiology
      Publisher: Springer Science and Business Media LLC

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references115

          • Record: found
          • Abstract: not found
          • Article: not found

          2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

          Theresa A McDonagh, Marco Metra, Marianna Adamo … (2021)
          Article 0 comments Cited 3058 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

            Bernard Zinman, Christoph Wanner, John M. Lachin … (2015)
            The effects of empagliflozin, an inhibitor of sodium-glucose cotransporter 2, in addition to standard care, on cardiovascular morbidity and mortality in patients with type 2 diabetes at high cardiovascular risk are not known.
            Article 0 comments Cited 2526 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

              John J.V. McMurray, Scott D. Solomon, Silvio E Inzucchi … (2020)
              In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through glucose-independent mechanisms. More data are needed regarding the effects of SGLT2 inhibitors in patients with established heart failure and a reduced ejection fraction, regardless of the presence or absence of type 2 diabetes.
              Article 0 comments Cited 2017 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Contributors
                Biykem Bozkurt: (View ORCID Profile)
                Journal
                Title: Nature Reviews Cardiology
                Abbreviated Title: Nat Rev Cardiol
                Publisher: Springer Science and Business Media LLC
                ISSN (Print): 1759-5002
                ISSN (Electronic): 1759-5010
                Publication date (Electronic): March 26 2024
                Article
                DOI: 10.1038/s41569-024-00997-0
                SO-VID: 64acbc34-0372-4d55-bfda-5702b9b60632
                Copyright © © 2024
                License:

                https://www.springernature.com/gp/researchers/text-and-data-mining

                https://www.springernature.com/gp/researchers/text-and-data-mining

                History

                Data availability:

                Comments

                Comment on this article